Concept Foundation is pleased to announce that India’s Drugs Technical Advisory Board recently agreed to the introduction of Depot-medroxyprogesterone acetate, or DMPA, under the National Family Planning Programme, although it has been registered for use in India’s private health sector since 1993. Past attempts at introducing the injectable contraceptive into the public sector had failed after meeting with objections from various civil society groups. However, with no issues being noted in the past 20 years of use in the private sector, DMPA has been approved for use, with doctors recommending introduction throughout India at all health system levels. This will have the benefit of giving women in India a larger choice in family planning methods.
See the original article here.